(+/-)-(1S*,3R*,4S*,5S*,7S*,8R*,9S*,10R*,12R*)-{4,5,7-TRICHLOR-3-ETHOXY-12-ISOPROPYL-6,6-DIMETHOXY-9-METHYL-2-OXATETRACYCLO-[6.4.0.0(3,7).0(5,9)]-DODEC-10-YL}-
Compound with spectra: 1 NMR
![(+/-)-(1S*,3R*,4S*,5S*,7S*,8R*,9S*,10R*,12R*)-{4,5,7-TRICHLOR-3-ETHOXY-12-ISOPROPYL-6,6-DIMETHOXY-9-METHYL-2-OXATETRACYCLO-[6.4.0.0(3,7).0(5,9)]-DODEC-10-YL}-](/api/compound/Ca96fn3UJSZ.png?ph=true&h=300&w=458 "(+/-)-(1S*,3R*,4S*,5S*,7S*,8R*,9S*,10R*,12R*)-{4,5,7-TRICHLOR-3-ETHOXY-12-ISOPROPYL-6,6-DIMETHOXY-9-METHYL-2-OXATETRACYCLO-[6.4.0.0(3,7).0(5,9)]-DODEC-10-YL}-")
| SpectraBase Compound ID | Ca96fn3UJSZ |
|---|---|
| InChI | InChI=1S/C20H31Cl3O7S/c1-8-28-19-15(21)18(23)16(4)12(30-31(7,24)25)9-11(10(2)3)13(29-19)14(16)17(19,22)20(18,26-5)27-6/h10-15H,8-9H2,1-7H3/t11-,12?,13?,14+,15+,16-,17+,18+,19-/m0/s1 |
| InChIKey | UBVCEEXTMXPRTM-LBKFPCBISA-N |
| Mol Weight | 521.88 g/mol |
| Molecular Formula | C20H31Cl3O7S |
| Exact Mass | 520.085608 g/mol |
| Enantiomer InChIKey | UBVCEEXTMXPRTM-LOHVKTLSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
tetramethyl (2.alpha.,3.alpha.,6.beta.,8.beta.,10.beta.,12.beta.,15.alpha.,16.alpha.)-19-endo,23-endo,27-exo-9,21-dioxo-7,11,19,23,27,28-hexaoxaundecacyclo[15.7.2.1(2,16),1(4,14).0(1,17).0(3,15).0(5,13).0(6,8).0(10,12).0(18,20).0(22,24)]octacosa-5(13),25-diene-3,15,25,26-tetracarboxylate
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
41,42,43,44,45,46,47,48-Octamethoxy-4,9,14,19,24,29,34,39-octamethylnonacyclo[35.3.1.1(2,6).1(7,11).1(12,16).1(17,21).1(22,26).1(27,31).1(32,36)]octatetraconta-1(41),2,4,6(48),7,9,11(47),12,14,16(46),17,19,21(45),22,24,26(44),27,29,31(43),32,34,36(42),37,39-tetracosaene
(2R,3R,4S,6E,8R,9S,10S,11R,12R,13R)-1-tert-Butyldimethylsilyloxy-2,4,6,8,10,12-hexamethyl-3-(3,4-dimethoxybenzyloxy)-9,11-isopropylidenedioxy-13-(4-methoxybenzyloxy)-12-methoxymethoxypentacec-6-en-5-one
Diethyl 4,4''-{[(1R,2R)-cyclohexane-1,2-diyl]dinitrilo-3,3,3',3'-tetramethyl-4,4'-[(2",3",7",8"-tetrahydro-2",2",3",3",7",7",8',8'-octamethyl-11"H-dipyrrin-1",9"-diylidene)-dinitrilo]-bis[butanoato](1-)cobalt(III)
(2S,5R,6R,10R,12S,13S,14S,15R)-2-[(2R,5R,6S)-5-benzyloxy-5-ethyl-6-methyltetrahydropyran-2-yl]-2,5-bis(tert-butyldimethylsilyloxy)-13,15-isopropylidenedioxy-6-(4-methoxybenzyloxy)-10,12-dimethylheptadec-7-yn-9-one1-yne
Dispiro[piperidine-4,2'-[7,14,24,31]tetraoxapentacyclo[30.2.2.23,6.215,18.220,23]dotetraconta[3,5,15,17,20,22,32,34,35,37,39,41]dodecaen e-19',4''-piperidine], 1,1''-diacetyl-5',33'-dibromo-16',22',36',37',40',41'-hexamethyl-
Spiro[12,15:17,20-dietheno-6H,16H,22H-dibenzo[b,d][1,6,12,22]tetraox acycloheptacosin-16,4'-piperidine]-1,31-dimethanamine, 7,8,9,10,23,24,25,26-octahydro-N,N,N',N',1',13,19,32,35-nonamethyl-, (S)-
| Title | Journal or Book | Year |
|---|---|---|
| Versuche zur enantiomerenreinen Synthese des Chatancins, 1. Mitt. Synthese von (1R,2S,6S,7R,8S,3?S)-2-(4?-Benzyloxy-3?-methylbutoyl)-7-hydroxy-8-isopropyl-1-methylbicyclo [4.4.0]decan-4-on | Monatshefte f�r Chemie Chemical Monthly | 1994 |